Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I expect some silly so and so will oblige them soon enough.
Oven must be nearly up to temperature. RNS next week?
...
Jobs advertised in the past 4 weeks https://ua.ingamejob.com/en/company/leap-gaming
From a couple of days ago
https://sentienbiotech.com/news/
Why don’t you just click on his name and read past posts if not a hold he has been , fair chance he put them in the bottom draw , maybe time now to get them out and dust them down lol, GL.
But are you a holder, GardenEye? I could not agree more with your view. Like many on AIM, it's a wait and see job. The good thing is it is an IT with several interests, so the risk is spread.
I'm just jealous. You can buy FFWD now at his price? Lucky you. Over the next few months we will see multiples of this SP. It's an SP bonanza & a dividend bonanza too IMO. After so long the potential is now going to start shining through. Anything under 10p is a staggering steal. Don't for one second believe me, but do look at LEAP GAMING, do look at Portage, do look at Emmac, do look at YOOMA! do look at Juvenescense! Lucky, lucky you. And good luck.
I think there’s more to this story than meets the eye Mat, but I’m sure we will find out soon.
Dr. Walters is an experienced entrepreneur and drug developer with leadership in the development of over 30 drugs in multiple therapeutic areas involving diverse technologies, leading to five new oncology drug approvals. His previous positions include Executive Director of Global Oncology Clinical Research and Business Development for Bristol-Myers Squibb, and Medical Director at Millennium Pharmaceuticals. Dr. Walters currently is CEO and Director of Portage Biotech, a publicly traded clinical stage biopharmaceutical company developing an innovative portfolio of immuno-oncology assets. He is also founder of seven of Portage’s portfolio companies.
https://www.globenewswire.com/news-release/2020/11/25/2133693/0/en/ENZO-BIOCHEM-ANNOUNCES-APPOINTMENT-OF-IAN-B-WALTERS-MD-TO-ITS-BOARD-OF-DIRECTORS.html
With Cannabinoid Ingredients on the Rise, Hempathy Becomes an Early Market Entrant in China’s Next Big Beauty Trend
We’re thrilled to partner with Drake and Future State Brands to launch Hempathy in the lucrative Chinese market at a time when cannabinoid beauty is really taking off,”— Ron Wardle, Co-CEO of Yooma
LOS ANGELES, CALIFORNIA, U.S., November 25, 2020 /EINPresswire.com/ -- Future State Brands announces today its official consumer market entry into China with the launch of Hempathy on Alibaba’s Tmall Global platform. Hempathy is a direct-to-consumer brand providing hemp-based skincare products with a plant-powered approach. As a result of Future State Brands’ first international expansion, Hempathy becomes the first U.S. hemp-based beauty brand to launch in China.
Future State Brands oversees a growing portfolio of hemp, CBD and lifestyle brands. Recognizing the growing demand for cannabinoid beauty products in China, Future State Brands partnered with CBD and hemp social commerce and cross-border specialist Yooma Corp., to launch Hempathy prior to the country’s notorious Singles Day on November 11, 2020. Yooma is a leader in launching western brands in China and other Asian markets through Yooma’s various sales and distribution channels including Tmall Global.
“China is in the early stages of cannabinoid legalization reminiscent of the legalization journey in North America. With 1.4 billion consumers and the recent acceptance of CBD for topical skincare, the market opportunity became clear to be an early brand into what we know will be a sizable hemp-based beauty trend in the coming years,” said Drake Sutton-Shearer, CEO and Founder of Future State Brands.
Hempathy is available via the Peach & Coco Tmall Global store, a Yooma-owned eCommerce retailer. Through this partnership, Future State Brands will focus on rapid expansion in additional sales channels in an effort to move with the momentum and become a leader in China’s cannabinoid beauty market.
“We’re thrilled to partner with Drake and Future State Brands to launch Hempathy in the lucrative Chinese market at a time when cannabinoid beauty is really taking off,” said Ron Wardle, Co-CEO of Yooma. “We project a $15 billion market opportunity over the next five years in China and early indicators show that to be very much on track. We’re excited to see Hempathy lead the charge on educating around hemp-based beauty and flourish in this next chapter.”
Hempathy is currently available for purchase in the U.S. on Hempathyliving.com, via Amazon, Walmart, and with additional select retailers in 2021. The brand was included in Allure’s “Best of Beauty 2020”, with additional coverage in Vogue, Harper's Bazaar, Elle, and InStyle Magazine. Hempathy is a recent 2020 nominee for the Los Angeles Business Journal Beauty Awards.
About YOOMA CORP.
Yooma Corp. is Asia’s leading hemp & CBD Lifestyle social commerce company, headquartered in Toronto with offices in Shanghai, Tokyo, a
Get Ready for a lot of YOOMA based PR. I think it's about to come to fruition.
This article is a little out of date (June). However, has an interesting discussion on virtual sports, including an interview with the managing director of IMG Arena, with whom we own Leap. He notes that instant football had been growing at 23% per month since it launched in January 2019. https://www.gamblinginsider.com/friday/tgif/tgif-2020-25.pdf?new1
“This is not another CBD brand. Hempathy is the first U.S.A. pure hemp-seed oil beauty brand to launch in China,” says Drake Sutton-Shearer, CEO and founder of Future State Brands, when sharing an exclusive first look into the launch of his brand in China.
In partnership with Yooma Corp., a CBD and hemp social commerce company focused on Asian markets, Future State Brands is launching its Hempathy brand on Alibaba’s Tmall Global platform. Customers in China will now be able to get the hemp-based skincare products made in the U.S. via the Peach & Coco Tmall Global store, a Yooma-owned eCommerce retailer.
A Rapidly Growing Market
According to Sutton-Shearer, Future State Brands’ decision to enter the Chinese market responded to the rising demand for natural products containing cannabinoids.
Hempathy
“China is in the early stages of a legalization of cannabinoid products like CBD and hemp; it’s reminiscent of the journey in North America. With topical cannabinoid skin care now legal, hundreds of brands have applied for CFDA registration (a legal registration for retail distribution) over the last year and a half,” he says. “Marrying that with the fact the Asia Pacific region is the world largest cosmetics market, the opportunity was ripe for Future State Brands to launch plant-powered skincare brand Hempathy into China as a first mover hemp-only premium beauty brand from the USA.”
The executive explains that, while there have been a few Western-owned CBD brands that launched in China recently, Hempathy is the first U.S.-made, pure hemp-seed oil beauty brand to launch in the country.
The announcement comes barely a month after Uncle Bud’s, a hemp and CBD brand backed by Earvin “Magic” Johnson launched its CBD products line in the Asian country.
A Challenging Endeavor
While the Chinese market has huge potential, barriers to entry are a bit higher than usual, and so is reaching consumers. Thus, the partnership with Yooma.
“Yooma co-CEO Ron Wardle has spent the better part of 30 years helping to launch and manage brands in the Asia Pacific markets,” explains Sutton-Shearer. “The company has an international and multicultural team of experts who have enabled us to launch within our desired timeline.”
Yooma co-CEO, Ron Wardle concludes: “China represents an incredible opportunity for Hempathy and we are thrilled to be working with Drake and his team, streamlining their launch and growth on Tmall Global. We recognize the rising demand from Chinese consumers seeking the latest global beauty trends including new ingredients like hemp infused beauty products.”
Javier Hasse
Brilliant Camkite. Lols
Following a 12% upswing for our portfolio this week, thought we would come back down to earth and look in to see what some of you were saying, but it is the usual chat and the usual bit of niggling between some of you.
Approaching 8p and that is were we think it will get stuck unless there is good news or a revaluation. Only those with vision or have had others doing research for them that makes the share look as though it is very very cheap will buy above 8p. So all of you who keep going on about it being worth 30p etc put your hands in your pockets and push it up to 30p, but you will have a lot of sellers making it very hard for you to get to 30p without the good news we are all hoping for. Most investors will not buy stocks above the NAV . A stock is revalued upwards then they buy it instead of buying before the revaluation. Even if it belies us and goes above the 8p mark nothing much will happen until we get the news of what our investments have done. So as we have constantly said forget it and just show some patience. Take care all.
2072 Parish paper.
“Doggo, laid to rest with his FFWD shares, forever trusting, forever patient, forever 7p, RIP”
Yes agree on that , if it takes a little longer so be it, but share price has to go up for everyone concerned , we’ve said news stacked up on a regular basis but now it is , Portage go nicely up 25% in the past week or so now just waiting on news on uplist to the Nasdaq , results soon trading update and a higher Nav , that will do for a start taking us into a new year, then surely this will be the year for FFWD.
Yes I did say 30p by end Q1 based on companies IPO, uplisting to Nasdaq, premium series raise, reversing into a listed company, trade sale etc.
Until they happen then we may spend an unspecified/ indefinite amount of time in this range.
Both are equally valid possibilities.
Let it happen in its own time, I’m content holding for as long as it takes. Investee news is constant and is clearly increasing. The Portage PR in the next few days should please us all.
Are you drunk DU?
His Missus must have gone to Netto and left the drinks cabinet unlocked
Glad you said that and not me as he would of said I’m being negative again lol, Ed said around Easter I think we will have to sell we can’t keep buying , but don’t think there will be a dividend every time we sell something, and don’t forget the warrants they’ve been awarded they have to hit a higher share price before they kick on , so I do expect a higher share price, in fact didn’t you say not so long ago 30p End Q1.
'I realise you're not a fan of ramping...'
You must be new here, pmsl!
"We may very well remain in the current price range indefinitely. The long term holders will be rewarded via dividends as and when the investee companies list or FFWD exit via a trade sale..I’ve never viewed FFWD as a traders stock due to how illiquid it has proved to be over the years."
That makes absolutely no sense.
Out of interest, if this company had great prospects on the horizon, investee companies were going up in value, what do you expect the SP to do ? Remain at the same price it was when things wern't looking so rosy ?
Or indeed if " long term holders will be rewarded via dividends" do you still expect it to be 8p to buy ?
BTW you don't have to be a long term holder to be rewarded of dividends you just have to buy before they pay a dividend, and if they are paying good dividends...... what do you expect the SP to do ?
FFWD went to a high of ? 30p (give or take) ... no reason that it won't go there again... equally no reason why people cannot enjoy 100/200% trade on the way up.
I realise you're not a fan of ramping but that logic doesn't make any sense.
We may very well remain in the current price range indefinitely. The long term holders will be rewarded via dividends as and when the investee companies list or FFWD exit via a trade sale. That’s were we will make our return not via fleeting spikes in SP.I’ve never viewed FFWD as a traders stock due to how illiquid it has proved to be over the years. It is a buy and hold stock, if you believe the investee companies offer a significant return on investment.Because FFWD have invested at seed/series A prices the returns on investment would be phenomenal if any of the companies prove up their potential.
I don’t think they get your joke PF, he did asked to be called a ramper lol